148 related articles for article (PubMed ID: 14969668)
21. Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C.
Contraception; 1997 Dec; 56(6):341-52. PubMed ID: 9494767
[TBL] [Abstract][Full Text] [Related]
22. The frameless GyneFix intrauterine implant: a major improvement in efficacy, expulsion and tolerance.
van Kets H; Vrijens M; Van Trappen Y; Delbarge W; van der Pas H; Temmerman M; Depypere H; Batar I; Barri P; Martinez F
Adv Contracept; 1995 Jun; 11(2):131-42. PubMed ID: 7491854
[TBL] [Abstract][Full Text] [Related]
23. A pilot study on the acceptability of levonorgestrel-releasing intrauterine device by young, single, nulliparous Chinese females following surgical abortion.
Li CF; Lee SS; Pun TC
Contraception; 2004 Mar; 69(3):247-50. PubMed ID: 14969674
[TBL] [Abstract][Full Text] [Related]
24. Intrauterine devices and intrauterine systems.
ESHRE Capri Workshop Group
Hum Reprod Update; 2008; 14(3):197-208. PubMed ID: 18400840
[TBL] [Abstract][Full Text] [Related]
25. GyneFIX. The frameless intrauterine contraceptive implant--an update for interval, emergency and postabortal contraception.
Wildemeersch D; Batár I; Webb A; Gbolade BA; Delbarge W; Temmerman M; Dhont M; Guillebaud J
Br J Fam Plann; 1999 Jan; 24(4):149-59. PubMed ID: 10023101
[TBL] [Abstract][Full Text] [Related]
26. Experience of IUD/IUS insertions and clinical performance in nulliparous women--a pilot study.
Brockmeyer A; Kishen M; Webb A
Eur J Contracept Reprod Health Care; 2008 Sep; 13(3):248-54. PubMed ID: 18821462
[TBL] [Abstract][Full Text] [Related]
27. Outcomes at 1 year for the first 200 patients fitted with GyneFix at Margaret Pyke Centre.
Masters T; Everett S; May M; Guillebaud J
Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):65-70. PubMed ID: 12201324
[TBL] [Abstract][Full Text] [Related]
28. [Intrauterine devices in general practice: a prospective study of 300 insertions].
Marret H; Golfier F; Vollerin F; Legoaziou MF; Raudrant D
J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):465-70. PubMed ID: 12379830
[TBL] [Abstract][Full Text] [Related]
29. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
[TBL] [Abstract][Full Text] [Related]
30. Precision intrauterine contraception may significantly increase continuation of use: a review of long-term clinical experience with frameless copper-releasing intrauterine contraception devices.
Wildemeersch D; Pett A; Jandi S; Hasskamp T; Rowe P; Vrijens M
Int J Womens Health; 2013; 5():215-25. PubMed ID: 23658502
[TBL] [Abstract][Full Text] [Related]
31. [Copper-silver T: The classic T resuscitated].
Jarvela S; Allonen H
Contracept Fertil Sex (Paris); 1986 Jan; 14(1):45-7. PubMed ID: 12341240
[TBL] [Abstract][Full Text] [Related]
32. Acceptability and clinical performance of a copper-containing frameless IUCD in Hong Kong.
Wong CY; Ng WL; Lo ST; Fan YS
Contraception; 2005 Jan; 71(1):51-4. PubMed ID: 15639073
[TBL] [Abstract][Full Text] [Related]
33. The GyneFix implant systems for interval, postabortal and postpartum contraception: a significant advance in long-term reversible contraception. International Study Group on Intrauterine Drug Delivery.
Van Kets H; Van der Pas H; Thiery M; Wildemeersch D; Vrijens M; Van Trappen Y; Temmerman M; DePypere H; Delbarge W; Dhont M; Defoort P; Schacht EH; Bàtàr I; Barri P; Martinez F; Iglesias Cortit LH; Creatsas G; Shangchun W; Xiaoming C; Zuan-chong F; Yu-ming W; Andrade A; Reinprayoon D; Pizarro E
Eur J Contracept Reprod Health Care; 1997 Mar; 2(1):1-13. PubMed ID: 9678104
[TBL] [Abstract][Full Text] [Related]
34. Intrauterine contraception in adolescent women. The GyneFix intrauterine implant.
Wildemeersch D; Van Kets H; Vrijens M; Delbarge W; Van Trappen Y; Temmerman M; Depypere H; Thiery M
Ann N Y Acad Sci; 1997 Jun; 816():440-50. PubMed ID: 9238300
[TBL] [Abstract][Full Text] [Related]
35. A randomized trial on the clinical performance of Nova T380 and Gyne T380 Slimline copper IUDs.
Haugan T; Skjeldestad FE; Halvorsen LE; Kahn H
Contraception; 2007 Mar; 75(3):171-6. PubMed ID: 17303485
[TBL] [Abstract][Full Text] [Related]
36. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
[TBL] [Abstract][Full Text] [Related]
37. Interim insertion of the ML Cu 250 intrauterine contraceptive device.
Vankets He Thiery M; Van Der Pas H; Delbeke L Van Os WA; Tauber PE; Dombrowicz N; Macdonald JS; Haspels AA; Drogenduk AC
Contracept Deliv Syst; 1980 Apr; 1(2):149-54. PubMed ID: 12336242
[TBL] [Abstract][Full Text] [Related]
38. Comparative study on contraceptive efficacy and clinical performance of the copper/low-density polyethylene nanocomposite IUD and the copper T220C IUD.
Yu J; Li J; Li HG; Li JX; Xie CS; Zhu CH
Contraception; 2008 Oct; 78(4):319-23. PubMed ID: 18847581
[TBL] [Abstract][Full Text] [Related]
39. Subject and clinician experience with the levonorgestrel-releasing intrauterine system.
Jensen JT; Nelson AL; Costales AC
Contraception; 2008 Jan; 77(1):22-9. PubMed ID: 18082662
[TBL] [Abstract][Full Text] [Related]
40. Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system.
Wildemeersch D; Rowe PJ
Contraception; 2005 Jun; 71(6):470-3. PubMed ID: 15914139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
